These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2950190)

  • 1. [Chronic renal failure: present and future. Pathophysiology and metabolic abnormalities--uremic toxin, small molecular compounds].
    Orita Y; Ando A
    Nihon Naika Gakkai Zasshi; 1986 Nov; 75(11):1545-9. PubMed ID: 2950190
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue and blood cell concentration of methylguanidine in rats and patients with chronic renal failure.
    Orita Y; Ando A; Tsubakihara Y; Mikami H; Kikuchi T; Nakata K; Abe H
    Nephron; 1981; 27(1):35-9. PubMed ID: 7219635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity arising from guanidine compounds: role of methylguanidine as a uremic toxin.
    Barsotti G; Bevilacqua G; Morelli E; Cappelli P; Balestri PL; Giovannetti S
    Kidney Int Suppl; 1975 Feb; (3):299-301. PubMed ID: 1057702
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of low protein diet and surplus of essential amino acids on the serum concentration and the urinary excretion of methylguanidine and guanidinosuccinic acid in chronic renal failure.
    Ando A; Orita Y; Nakata K; Tsubakihara Y; Takamitsu Y; Ueda N; Yanase M; Abe H
    Nephron; 1979; 24(4):161-9. PubMed ID: 492426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diamine oxidase (histaminase) in chronic renal disease and its inhibition in vitro by methylguanidine.
    Gäng V; Berneburg H; Hennemann H; Hevendehl G
    Clin Nephrol; 1976 Apr; 3(2):171-7. PubMed ID: 819194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that methylguanidine is retained in chronic renal failure.
    Giovannetti S; Biagini M; Cioni L
    Experientia; 1968 Apr; 24(4):341-3. PubMed ID: 5705180
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J; Klahr S; Bricker NS
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemistry of renal failure.
    Wills MR; Savory J
    Ann Clin Lab Sci; 1981; 11(4):292-9. PubMed ID: 7023344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic pathway of guanidino compounds in chronic renal failure.
    Mikami H; Orita Y; Ando A; Fujii M; Kikuchi T; Yoshihara K; Okada A; Abe H
    Adv Exp Med Biol; 1982; 153():449-58. PubMed ID: 7164918
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of methylguanidine in dogs with acute and chronic renal failure.
    Brooks DP; Rhodes GR; Woodward P; Boppana VK; Mallon FM; Griffin HE; Kinter LB
    Clin Sci (Lond); 1989 Dec; 77(6):637-41. PubMed ID: 2605868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies of plasma and urine levels between uremic peak 2a and guanidino compounds].
    Koide K; Toyama J; Inoue N; Koshikawa S; Akizawa T; Takahashi K; Hidaka S; Yamane Y; Nakao M; Ono S
    Nihon Jinzo Gakkai Shi; 1987 Apr; 29(4):485-92. PubMed ID: 3656706
    [No Abstract]   [Full Text] [Related]  

  • 12. Implications of dietary therapy.
    Giovannetti S; Balestri PL; Biagini M; Menichini G; Rindi P
    Arch Intern Med; 1970 Nov; 126(5):900-5. PubMed ID: 5475715
    [No Abstract]   [Full Text] [Related]  

  • 13. Guanidino compounds and hemodialysis.
    Ochiai Y; Abe S; Yamada T; Tada K; Kosaka F
    Adv Exp Med Biol; 1982; 153():459-64. PubMed ID: 7164919
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure.
    Tanaka A; Takahashi Y; Mizokuchi M; Shimada N; Koide H
    Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nitrogen metabolism and chronic renal insufficiency].
    Richet G; Meyerovitch A
    Bull Mem Soc Med Hop Paris; 1968; 119(12):977-80. PubMed ID: 5719333
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on guanidine compounds in uremia: reevaluation of serum GSA in relation to acute symptoms of uremia (author's transl)].
    Tofuku Y; Kuroda M; Kita T; Takeda R
    Nihon Jinzo Gakkai Shi; 1980 Mar; 22(3):249-58. PubMed ID: 7382166
    [No Abstract]   [Full Text] [Related]  

  • 17. [Guanidine derivatives in renal failure. Evaluation of guanidine derivative determination methods and their clinical application, with special reference to methylguanidine].
    Gejo F
    Nihon Jinzo Gakkai Shi; 1974 Apr; 16(4):379-89. PubMed ID: 4474523
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythrocyte deformability in acute and chronic kidney failure patients].
    Grinshteĭn IuI; Kalinina IA; Vitman TV
    Ter Arkh; 1986; 58(12):91-3. PubMed ID: 3824225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentration and urinary excretion of guanidine derivatives in normal subjects and patients with renal failure.
    Sawynok J; Dawborn JK
    Clin Exp Pharmacol Physiol; 1975; 2(1):1-15. PubMed ID: 1126056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uremic intoxication.
    Giovannetti S; Barsotti G
    Nephron; 1975; 14(2):123-33. PubMed ID: 1093053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.